ArticleJournal of hematology & oncology2018
Accurate control of dual-receptor-engineered T cell activity through a bifunctional anti-angiogenic peptide.
Erhao Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
22 papers cite it
this papercites it